ENGWE Enters Electric Dirt Riding with Eagle, Built for a New Generation of Riders

ENGWE Enters Electric Dirt Riding with Eagle, Built for a New Generation of Riders

ENGWE enters electric dirt riding with Eagle, bringing together young rider Carter Metcalfe and freeride professional Tom van Steenbergen in a story of passion, progression and freedom — set to continue this October at Red Bull Rampage in Utah. NEW...

Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)

Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)

SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone...

Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS

Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Jan. 13, 2026 /PRNewswire/ -- Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral...

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells...

Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs

Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs

BOSTON, Nov. 17, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its...

Silicon Quantum Computing Selected by DARPA to Advance into Second Stage of Quantum Benchmarking Initiative

Silicon Quantum Computing Selected by DARPA to Advance into Second Stage of Quantum Benchmarking Initiative

Advancement to second stage of DARPA Quantum Benchmarking Initiative validates promise of Silicon Quantum Computing's in-house manufacturing for building quantum computers using engineered atoms in silicon SYDNEY, Nov. 7, 2025 /PRNewswire/ --...

OnCusp Therapeutics Appoints Dimitry Nuyten, M.D., Ph.D., as Chief Medical Officer

OnCusp Therapeutics Appoints Dimitry Nuyten, M.D., Ph.D., as Chief Medical Officer

PRINCETON, N.J., June 23, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today...

Mobile industry emissions down 8%, but pace must double to hit net zero

Mobile industry emissions down 8%, but pace must double to hit net zero

LONDON, June 18, 2025 /PRNewswire/ -- The mobile industry's operational emissions fell by 8% between 2019 and 2023, even as mobile connections grew by 9% and data traffic quadrupled, according to the GSMA's fifth annual Mobile Net Zero report...

Univar Solutions Publishes 2024 Environmental, Social and Governance (ESG) Report

Univar Solutions Publishes 2024 Environmental, Social and Governance (ESG) Report

As the Company enters the final year of its current ESG goals highlights show significant progress on all fronts, including its Sustainable & Natural Products portfolio. DOWNERS GROVE, Ill., June 10, 2025 /PRNewswire/ -- Univar Solutions LLC...

GAR Profits Surge in Competitive Market Environment During the First Quarter of 2025

GAR Profits Surge in Competitive Market Environment During the First Quarter of 2025

Net profit for the quarter surged by 47% year-on-year to US$55 million. Growth in plantation output helped to offset softer downstream performance, resulting in a first quarter 2025 EBITDA margin of over 8.5%. SINGAPORE, May 15, 2025 /PRNewswire/ --...

  • 1
  • 2
  • menu
    menu